HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsPricing
Theme 		Help

NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

DVAX

Dynavax Technologies Corp

Last Close
May 08 • 04:00PM ET
9.69
Dollar change
-0.03
Percentage change
-0.31 		%
Healthcare • Drug Manufacturers - Specialty & Generic • USA • NASD
Peers: JNJ PFE MRNA GILD BNTX AZN REGN NVAX VIR VXRT
 | Held by: IJR VTI IWM VXF XBI IWO SPSM VTWO IBB IJS
Scroll to Statements
IndexRUT P/E- EPS (ttm)-0.53 Insider Own4.66% Shs Outstand123.70M Perf Week-15.59%
Market Cap1.16B Forward P/E18.15 EPS next Y0.53 Insider Trans-1.00% Shs Float114.49M Perf Month-17.53%
Income-60.07M PEG- EPS next Q0.10 Inst Own104.50% Short Float15.60% Perf Quarter-26.09%
Sales294.62M P/S3.95 EPS this Y-229.00% Inst Trans-3.06% Short Ratio6.75 Perf Half Y-17.81%
Book/sh4.29 P/B2.26 EPS next Y306.98% ROA-6.22% Short Interest17.86M Perf Year-16.75%
Cash/sh5.51 P/C1.76 EPS next 5Y53.79% ROE-10.45% 52W Range9.62 - 14.63 Perf YTD-24.12%
Dividend Est.- P/FCF21.54 EPS past 5Y- ROI-7.35% 52W High-33.77% Beta1.15
Dividend TTM- Quick Ratio10.84 Sales past 5Y177.58% Gross Margin82.27% 52W Low0.73% ATR (14)0.51
Dividend Ex-Date- Current Ratio11.93 EPS Y/Y TTM-783.38% Oper. Margin-3.10% RSI (14)28.00 Volatility5.44% 4.81%
Employees405 Debt/Eq0.55 Sales Y/Y TTM24.76% Profit Margin-20.39% Recom1.80 Target Price24.52
Option/ShortYes / Yes LT Debt/Eq0.54 EPS Q/Q-1048.66% Payout0.00% Rel Volume1.21 Prev Close9.72
Sales Surprise-2.04% EPS Surprise-2773.61% Sales Q/Q34.21% EarningsMay 06 AMC Avg Volume2.65M Price9.69
SMA20-11.37% SMA50-22.28% SMA200-19.83% Trades Volume3,195,280 Change-0.31%
Date Action Analyst Rating Change Price Target Change
Feb-11-25Downgrade Goldman Neutral → Sell $15 → $12
Feb-01-24Initiated Goldman Neutral $20
Sep-27-22Initiated JMP Securities Mkt Outperform $22
Jan-06-22Resumed Goldman Buy $38
Aug-06-21Initiated Goldman Buy $19
Aug-07-20Reiterated H.C. Wainwright Buy $14 → $12
Aug-03-20Reiterated H.C. Wainwright Buy $12 → $14
Jun-15-20Initiated Evercore ISI Outperform $14
Oct-18-19Initiated H.C. Wainwright Buy $13
Jul-11-19Upgrade Cantor Fitzgerald Neutral → Overweight $20
Show Previous Ratings
May-08-25 12:00PM
Dynavax Technologies (DVAX) Upgraded to Buy: Here's Why
(Zacks)
May-07-25 04:45PM
Dynavax Issues Statement and Mails Letter to Stockholders Emphasizing Record Financial Results and Continued Momentum
(PR Newswire) -10.99%
03:19AM
Dynavax Technologies Corp (DVAX) Q1 2025 Earnings Call Highlights: Record Revenue and Strategic ...
(GuruFocus.com)
May-06-25 05:15PM
Dynavax Technologies (DVAX) Reports Q1 Loss, Misses Revenue Estimates
(Zacks)
04:01PM
Dynavax Reports First Quarter 2025 Financial Results and Announces New Pipeline Programs
(PR Newswire)
08:00AM Loading…
08:00AM
Deep Track Capital Releases Investor Presentation on Dynavax Technologies
(Business Wire)
May-05-25 08:10AM
TG Therapeutics (TGTX) Lags Q1 Earnings Estimates
(Zacks)
May-01-25 08:00AM
Dynavax Announces Nationwide Harris Poll Survey Results Finding Americans Underestimate the Serious Consequences of Hepatitis B and Vaccine Protection Benefits
(PR Newswire)
Apr-29-25 07:30AM
Dynavax Highlights Superior Board Leadership Overseeing Long-Term Value Creation Strategy
(PR Newswire)
Apr-22-25 04:00PM
Dynavax to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025
(PR Newswire)
Apr-21-25 04:05PM
Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders
(Business Wire)
Apr-17-25 09:17AM
GSK's Pentavalent Meningococcal Jab Recommended for Use by ACIP
(Zacks)
07:15AM
Dynavax Files Definitive Proxy Statement and Sends Letter to Stockholders
(PR Newswire)
Apr-16-25 09:48AM
MURA Soars as it Explores Strategic Options Post Cancer Study Failures
(Zacks) -6.66%
08:52AM
DTIL Gets FDA's Fast Track Tag for Hepatitis B Gene Therapy, Stock Up
(Zacks)
08:00AM Loading…
08:00AM
Deep Track Capital Comments on Dynavax Technologies Rejection of Most Recent Settlement Offer
(Business Wire)
Apr-15-25 10:20AM
Buy The Dips, Sell The Rips
(Seeking Alpha)
Apr-11-25 11:57AM
KROS Initiates Exploring Strategic Alternatives, Stock Gains 18.5%
(Zacks)
Apr-10-25 10:53AM
PHIO Stock Soars as Safety Panel Clears Skin Cancer Drug for Next Dose
(Zacks) -8.81%
09:58AM
ANIX Gets New Patent for Breast Cancer Vaccine Technology, Stock Up
(Zacks)
Apr-09-25 12:57PM
3 Biotech Stocks Holding Their Own
(Seeking Alpha)
10:01AM
RXRX Doses First Patient in Early-Stage B-Cell Lymphomas Study
(Zacks)
Apr-08-25 12:18PM
AtriCure Drops 25%: Bargain Or Caution Sign?
(Seeking Alpha) -5.92%
11:29AM
PCRX Stock Soars on Exparel Patent Settlement With Generic Players
(Zacks)
11:21AM
RYTM Stock Rises 17% on Meeting Goals in Hypothalamic Obesity Study
(Zacks)
Apr-07-25 10:53AM
AZN Gets EU Nod for Expanded Use of Two Separate Cancer Drugs
(Zacks)
Apr-04-25 01:45PM
Bayer's Vividion Initiates Dosing in Early-Stage Cancer Study
(Zacks)
01:10PM
AMGN's Uplizna Gets FDA Nod for 2nd Rare Autoimmune Disease Indication
(Zacks)
09:37AM
PCRX Doses First Patient in Phase II PCRX-201 Gene Therapy Study
(Zacks)
Apr-03-25 05:40PM
Dynavax Files Preliminary Proxy Statement
(PR Newswire)
11:27AM Loading…
11:27AM
SNY's Rilzabrutinib Gets FDA's Orphan Drug Tag for Two Rare Diseases
(Zacks)
09:32AM
DNLI Begins Rolling BLA Submission for Hunter Syndrome Drug, Stock Up
(Zacks)
Apr-02-25 11:29AM
AXSM Stock Down on Top-Line Data From Depression Study on Solriamfetol
(Zacks)
Apr-01-25 10:55AM
VRTX Provides Mixed Updates for Type 1 Diabetes Pipeline Candidates
(Zacks)
09:31AM
AstraZeneca's Imfinzi Gets FDA Nod for Bladder Cancer Indication
(Zacks)
Mar-31-25 09:57AM
Moderna, biotech stocks slide following resignation of FDA official Peter Marks
(Yahoo Finance) -5.19%
Mar-28-25 09:45AM
Kodiak Q4 Loss Narrower Than Expected, Pipeline Development in Focus
(Zacks)
09:26AM
BEAM's IND for BEAM-302 in Genetic Disorder Study Gets FDA Clearance
(Zacks)
Mar-27-25 12:37PM
Bayer Licenses PRMT5 inhibitor From Suzhou Puhe BioPharma
(Zacks)
09:39AM
PLRX Stock Plunges 89% in 3 Months: Here's What Investors Should Know
(Zacks)
Mar-25-25 12:44PM
Will Alkermes' Proprietary Drugs Aid Growth Amid Stiff Competition?
(Zacks)
11:51AM
UBX Stock Down 29% on Mixed Results From Phase II Eye Disease Study
(Zacks)
Mar-24-25 02:36PM
EMA Accepts GSK's Filing for Expanded Use of Nucala in COPD
(Zacks)
Mar-21-25 12:46PM
Alnylam Gets FDA Nod for Expanded Use of Amvuttra in Cardiomyopathy
(Zacks)
12:44PM
OPTN Stock Soars 53% on Inking $330M Deal to be Acquired by Paratek
(Zacks)
12:39PM
Pacira Surges 66.8% in Six Months: How Should You Play the Stock?
(Zacks)
12:37PM
Mirum's Heavy Dependence on Livmarli for Revenues Remains a Woe
(Zacks)
12:17PM
PSTV Stock Surges as FDA Accepts Proprietary Name for Lead Drug
(Zacks)
09:26AM
ESPR to Study Bempedoic Acid in Pediatric Familial Hypercholesterolemia
(Zacks)
Mar-20-25 12:23PM
Puma Biotechnology Stock Rises 35% in 6 Months: Here's Why
(Zacks)
10:44AM
Why Dynavax Technologies (DVAX) Stock Might be a Great Pick
(Zacks)
10:19AM
IMVT Unlikely to Pursue Batoclimab for MG & CIDP Despite Success
(Zacks)
09:34AM
Novartis Reports Updated Positive Data From Phase III SMA Program
(Zacks)
Mar-19-25 10:59AM
JNJ's Nipocalimab Gets FDA's Fast Track Tag for Sjogren's Disease
(Zacks)
Mar-12-25 09:55AM
Wall Street Analysts See an 83.1% Upside in Dynavax Technologies (DVAX): Can the Stock Really Move This High?
(Zacks)
Mar-10-25 08:00AM
Deep Track Capital Sends Letter to Dynavax Technologies Board of Directors
(Business Wire)
Mar-06-25 06:00AM
Dynavax Announces Convertible Debt Refinancing and Common Stock Share Repurchase
(PR Newswire)
Mar-02-25 12:36PM
Is Dynavax Technologies Corporation (DVAX) the Best Small Cap Pharma Stock to Buy Now?
(Insider Monkey)
Feb-25-25 04:10PM
Dynavax to Participate in Upcoming Investor Conferences
(PR Newswire)
Feb-24-25 09:55AM
Wall Street Analysts Think Dynavax Technologies (DVAX) Could Surge 81.92%: Read This Before Placing a Bet
(Zacks)
Feb-21-25 12:59PM
MercadoLibre Stock Hits New High As Company Delivers Profits
(Investor's Business Daily)
02:14AM
Dynavax Technologies Corp (DVAX) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ...
(GuruFocus.com)
Feb-20-25 09:30PM
Dynavax Technologies (DVAX) Q4 2024 Earnings Call Transcript
(Motley Fool)
05:10PM
Dynavax Technologies (DVAX) Surpasses Q4 Earnings and Revenue Estimates
(Zacks)
04:15PM
Dynavax Technologies: Q4 Earnings Snapshot
(Associated Press Finance)
04:01PM
Dynavax Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Financial Guidance
(PR Newswire)
Feb-19-25 04:52PM
Dynavax Responds to Deep Track and Highlights Long-Term Value Creation Strategy
(PR Newswire)
09:00AM
Deep Track Capital Nominates Four Highly Qualified Candidates for Election to Dynavax Technologies Board of Directors at 2025 Annual Meeting
(Business Wire)
08:04AM
Investor Deep Track launches proxy fight at Dynavax, nominates 4 directors
(Reuters)
Feb-11-25 03:11PM
Goldman Sachs Turns Bearish On Vaccine Maker Dynavax Amid Shingles And Hepatitis B Uncertainty
(Benzinga)
Feb-06-25 05:42PM
Dynavax to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on February 20, 2025
(PR Newswire)
Jan-29-25 09:55AM
Wall Street Analysts Believe Dynavax Technologies (DVAX) Could Rally 93.2%: Here's is How to Trade
(Zacks)
Jan-27-25 06:00AM
Dynavax Advances Board Refreshment Program
(PR Newswire)
Jan-16-25 12:00PM
Dynavax Technologies (DVAX) Upgraded to Buy: Here's What You Should Know
(Zacks)
Jan-14-25 09:29AM
Dynavax Reports Revenue Growth and Defense Contract
(TipRanks)
Jan-13-25 09:00AM
Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Highlights
(PR Newswire)
Jan-03-25 08:30AM
Implied Volatility Surging for Dynavax Technologies (DVAX) Stock Options
(Zacks)
Nov-27-24 09:55AM
Does Dynavax Technologies (DVAX) Have the Potential to Rally 93.52% as Wall Street Analysts Expect?
(Zacks)
Nov-26-24 04:05PM
Dynavax to Present at the 7th Annual Evercore HealthCONx Conference
(PR Newswire)
Nov-25-24 09:03AM
Do Options Traders Know Something About Dynavax Technologies (DVAX) Stock We Don't?
(Zacks)
Nov-19-24 08:50AM
Dynavax Technologies Corporation (DVAX): This Small-Cap Stock Is Ready To Explode
(Insider Monkey)
Nov-11-24 12:00PM
Dynavax Technologies (DVAX) Upgraded to Buy: Here's Why
(Zacks)
09:55AM
Wall Street Analysts Predict an 88.32% Upside in Dynavax Technologies (DVAX): Here's What You Should Know
(Zacks)
08:00AM
Dynavax Announces $100 Million Accelerated Share Repurchase Program
(PR Newswire)
Nov-08-24 12:02PM
Dynavax Technologies Corp (DVAX) Q3 2024 Earnings Call Highlights: Record Hep B Sales and ...
(GuruFocus.com) +8.24%
Nov-07-24 11:15PM
Dynavax Technologies (DVAX) Q3 2024 Earnings Call Transcript
(Motley Fool)
05:25PM
Dynavax Technologies (DVAX) Q3 Earnings Surpass Estimates
(Zacks)
04:18PM
Dynavax Technologies: Q3 Earnings Snapshot
(Associated Press Finance)
04:02PM
Dynavax Reports Third Quarter 2024 Financial Results and Provides Business Updates
(PR Newswire)
04:01PM
Dynavax Announces $200 Million Share Repurchase Program
(PR Newswire)
Nov-01-24 06:33PM
Bath & Body Works, Paramount Global, and More Stocks See Action From Activist Investors
(Barrons.com)
Oct-29-24 08:30AM
Dynavax Adopts Limited-Duration Stockholder Rights Plan
(PR Newswire)
Oct-24-24 09:08PM
Deep Track Capital, LP Reduces Stake in Dynavax Technologies Corp
(GuruFocus.com)
04:10PM
Dynavax to Report Third Quarter 2024 Financial Results and Host Conference Call on November 7, 2024
(PR Newswire)
Oct-16-24 01:04PM
State Street Corp's Strategic Reduction in Dynavax Technologies Holdings
(GuruFocus.com)
Oct-09-24 05:07PM
Dynavax Technologies Corp (DVAX) Q2 2024 Earnings Call Highlights: Record HEPLISAV-B Sales and ...
(GuruFocus.com)
Sep-20-24 06:39PM
Lennar, Bitdeer, and More Stocks See Action From Activist Investors
(Barrons.com)
Sep-16-24 07:02PM
Deep Track Capital, LP Increases Stake in Dynavax Technologies Corp
(GuruFocus.com)
Sep-12-24 01:13AM
Federated Hermes, Inc. Reduces Stake in Dynavax Technologies Corp
(GuruFocus.com)
Sep-05-24 08:30AM
Lantheus Appoints Julie Eastland as New Board Member
(GlobeNewswire)
Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the provision of discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Emeryville, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Novack David FPresident & COOMar 24 '25Option Exercise6.8010,00068,05018,078Mar 26 05:04 PM
Novack David FPresident & COOMar 24 '25Sale14.0010,000140,0008,078Mar 26 05:04 PM
DAVID NOVACKOfficerMar 24 '25Proposed Sale14.0010,000140,000Mar 24 04:23 PM
Novack David FPresident & COOMar 18 '25Sale13.5814,020190,3928,078Mar 20 06:15 PM
DAVID NOVACKOfficerMar 18 '25Proposed Sale13.5814,020190,386Mar 18 04:17 PM
Novack David FPresident & COOMar 07 '25Sale14.3932,764471,47422,098Mar 10 09:44 PM
DAVID NOVACKOfficerMar 07 '25Proposed Sale14.3932,764471,376Mar 07 05:16 PM
CANO FRANCISDirectorMay 31 '24Sale11.933,61543,12736,905Jun 03 05:37 PM
CANO FRANCISDirectorMay 24 '24Option Exercise5.907,50044,25044,405May 28 08:18 PM
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
Affiliate • Advertise • Theme Settings • Contact • Help • Privacy • Do Not Sell My Data
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 FINVIZ.com. All Rights Reserved.